Saturday, October 4, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Mergers & Acquisitions

Intevac Shareholders Receive Final Payout Following Seagate Acquisition

Andreas Sommer by Andreas Sommer
October 4, 2025
in Mergers & Acquisitions, Semiconductors, Tech & Software
0
Intevac Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The corporate journey of Intevac has reached its conclusion. In a transaction finalized earlier this year, Seagate Technology has completed the full acquisition of the company, resulting in its immediate delisting from public markets. This development marks the definitive end for shareholders, with all trading of Intevac securities permanently terminated.

Acquisition Terms and Shareholder Compensation

Under the acquisition agreement, Seagate disbursed $4.00 in cash for each outstanding share of Intevac common stock. This base payment was supplemented by additional distributions to shareholders, including both special and quarterly dividend payments. When combined, these payments resulted in total compensation of $4.102 per share to Intevac investors.

The acquisition premium proved substantial for shareholders. The total consideration represented a 21 percent premium over Intevac’s closing share price on February 12, 2025—the final trading day before the acquisition announcement. When measured against the stock’s value from December 2024, when Intevac first disclosed its strategic repositioning, the premium reached an even more impressive 45 percent.

Final Trading and Corporate Status

The transaction reached its formal conclusion on March 31, 2025, immediately halting all market trading of Intevac shares. Beginning April 1, 2025, the company ceased to be listed on the Nasdaq exchange. Intevac now operates as a wholly-owned subsidiary within Seagate’s corporate structure.

Should investors sell immediately? Or is it worth buying Intevac?

Key transaction details include:
* Base acquisition price: $4.00 per share
* Special dividend distribution: $0.052 per share
* Quarterly dividend payment: $0.05 per share
* Final trading date: March 31, 2025

Financial Context Behind the Acquisition

The strategic rationale behind this acquisition becomes evident upon examining Intevac’s financial performance for fiscal year 2024. Despite achieving revenue growth to $64 million, the company recorded substantial net losses approaching $40 million during this period.

Profitability metrics deteriorated significantly, primarily driven by impairment charges and organizational restructuring costs. Within this challenging financial context, Seagate’s acquisition emerged as a logical strategic resolution. For Intevac shareholders, the transaction provided an advantageous exit opportunity with compensation at a notable market premium.

Ad

Intevac Stock: Buy or Sell?! New Intevac Analysis from October 4 delivers the answer:

The latest Intevac figures speak for themselves: Urgent action needed for Intevac investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 4.

Intevac: Buy or sell? Read more here...

Tags: Intevac
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Tucows Stock
Analysis

Tucows Shares Face Mounting Pressure as Downtrend Accelerates

October 4, 2025
Iteris Stock
Mergers & Acquisitions

Iteris Stock: A Chapter Closes Following Acquisition

October 4, 2025
Paratek Stock
Mergers & Acquisitions

Paratek’s Strategic Acquisition Signals New Growth Phase

October 4, 2025
Next Post
Workhorse Stock

Electric Vehicle Maker Workhorse Faces Critical Juncture

Chemomab TherapeuticsDRC Stock

Biotech Stock Faces Sustained Selling Pressure

Leju Holdings Stock

Penny Stock Leju Holdings Skyrockets in Unprecedented Rally

Recommended

AI-Medical

Title Lack of Recent Patent Activity Raises Concerns for Creative Medical Technology

2 years ago
Rheinmetall Stock

Rheinmetall Stock: Peace Talks Clash With Growth Prospects

2 months ago
Real Estate Investment Trading online

Goldman Sachs Analyst Raises Price Target for Hudson Pacific Properties

2 years ago
Beauty Industry Stock Market Today

XWELL Inc Unveils Ambitious Expansion Plans for Naples Wax Center Brand

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple Applovin BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Solo Brands Faces Mounting Crisis as Quarterly Results Disappoint

Genprex Shares Plunge Amid Heavy Selling Pressure

NextCure Shares Extend Biotech Sector Rally

Penny Stock Leju Holdings Skyrockets in Unprecedented Rally

Biotech Stock Faces Sustained Selling Pressure

Electric Vehicle Maker Workhorse Faces Critical Juncture

Trending

Applied Therapeutics Stock
Penny Stocks

Biotech Stock Soars on Regulatory Breakthrough

by Robert Sasse
October 4, 2025
0

Shares of Applied Therapeutics continued their remarkable ascent on Friday, climbing 7.04% to close at $1.00. This...

Enveric Biosci.inc.dl-,01 Stock

Enveric Biosciences Stock: Conflicting Signals Follow Key Milestone

October 4, 2025
Lyra Therapeutics Inc Stock

Biotech Firm Lyra Therapeutics Faces Critical Nasdaq Deadline

October 4, 2025
Solo Brands Stock

Solo Brands Faces Mounting Crisis as Quarterly Results Disappoint

October 4, 2025
Genprex Stock

Genprex Shares Plunge Amid Heavy Selling Pressure

October 4, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Biotech Stock Soars on Regulatory Breakthrough
  • Enveric Biosciences Stock: Conflicting Signals Follow Key Milestone
  • Biotech Firm Lyra Therapeutics Faces Critical Nasdaq Deadline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com